Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Everest Medicines Announces Up to HK$100 million Share Repurchase Program 2021-08-30 22:03
I-Mab Announces Upcoming Participation at September Conferences 2021-08-30 20:00
Alphamab Oncology Reports 2021 Interim Results and Business Highlights 2021-08-30 10:51
GeneQuantum announces Dr. Yi Xia as Senior Vice President of Statistics and Data Science 2021-08-30 10:00
Innovent to Present New Data on Sintilimab and Other Molecules at the European Society for Medical Oncology (ESMO) Congress 2021 2021-08-30 08:00
Hope Medicine Inc. Announced Dr. Henri Nico Doods as Chief Executive Officer 2021-08-30 08:00
InnoCare Releases 2021 Half Year Results and Business Highlights 2021-08-29 19:49
IONOVA Life Science Announces New Financing Round of USD $100 Million 2021-08-27 22:00
Laekna Therapeutics Receives IND Approvals in China and US for Phase Ib/III Global Multi-center Clinical Study of Afuresertib in combination with fulvestrant for patients with HR+/HER2- breast cancer 2021-08-27 11:20
Innovent and Bolt Biotherapeutics Announce Collaboration to Develop Three New Oncology Boltbody™ ISAC Programs 2021-08-27 08:00
Lynk Pharmaceuticals announced the completion of Series B financing of $50 million 2021-08-27 08:00
JNCCN Study Reveals Neuroendocrine Tumor Mortality Patterns to Inform Treatment Decisions 2021-08-27 03:30
Insilico Medicine and 4B Technologies Announce Strategic Collaboration in Advancing Novel Drug Discovery for Neurodegenerative Diseases 2021-08-27 03:22
PharmaBlock Announces the Appointment of Dr. Xudong Wei as Senior Vice President to Lead and Enhance Small Molecule CDMO Services 2021-08-26 23:00
3SBio announces 2021 interim results, with strong growth in core businesses and significant progress in clinical development 2021-08-26 22:09
Modern Chinese Medicine Announces Year 2021 Interim Results 2021-08-26 20:46
INOVIO Receives Authorization to Conduct Phase 3 Efficacy Trial of its COVID-19 DNA Vaccine Candidate, INO-4800 2021-08-26 20:00
RedHill Biopharma Reports Second Quarter 2021 Financial Results and Operational Highlights 2021-08-26 19:56
RedHill Biopharma's Opaganib Demonstrates Strong Inhibition of COVID-19 Delta Variant 2021-08-26 19:50
CStone Pharmaceuticals Announces 2021 Interim Results 2021-08-26 19:14
1 226 227 228 229 230 413